ArticleEuropean journal of medicinal chemistry2026

IMD-0354 optimization generates potent colistin adjuvants with in vivo activity and reduced eukaryotic toxicity.

Luke J Cowart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.